비교리스트

 카트 문의
시장보고서
상품코드
1493484

인공심장 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 치료법별, 지역별, 부문 예측(2024-2030년)

Artificial Heart Market Size, Share & Trends Analysis Report By Type (Heart-lung Machine, Total Artificial Heart), By Therapy (Destination Therapy, Bridge To Transplant, Bridge To Decision), By Region, And Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 125 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인공심장 시장 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 인공심장 시장 규모는 2024-2030년 CAGR 11.3%를 기록하며, 2030년에는 59억 4,000만 달러에 달할 전망입니다.

심혈관 질환의 부담 증가, 기술 발전, 노인 인구 증가, 심혈관 질환 위험 증가로 이어지는 생활습관 변화 등 다양한 요인으로 인해 이 시장은 크게 성장하고 있습니다. 전 세계 인구의 고령화에 따라 노년층의 심장질환 발병률이 증가하고 있습니다. 이러한 인구 추세는 심부전 등의 치료 옵션으로 인공심장에 대한 수요 증가에 기여하고 있습니다.

CVD의 세계 부담은 인구 고령화, 좌식 생활습관, 건강에 해로운 식습관으로 인해 증가하고 있으며, 2022년 5월 NCBI의 발표에 따르면 9,210만 명의 미국인이 CVD를 앓고 있으며, 2030년까지 43.9%가 CVD를 앓게 될 것으로 예상됩니다. 마찬가지로 영국 심장 재단의 2022년 7월 보고서에 따르면 2021년에는 남성 400만 명, 여성 360만 명이 심장 및 순환기 질환을 앓고 있을 것으로 예상됩니다. 심장병 환자의 예후를 개선하기 위한 연구에 대한 지속적인 투자가 인공심장 채택률을 높이고 있으며, 2024년 1월 CARMAT는 인공심장 Aeson의 새로운 소프트웨어 확장을 발표하여 실시간 결함 감지 및 지속적인 환자 치료를 제공하기 위한 제어 변경을 가능하게 함으로써 안전 프로파일을 강화했습니다. 프로파일을 강화하는 것을 목표로 했습니다.

인공심장 시장 보고서의 하이라이트

  • 유형별로는 좌심실 보조 순환 장비(LVAD) 분야가 2023년 77.40%의 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 전 세계 심부전 유병률 증가는 LVAD 시장 성장에 크게 기여하고 있습니다.
  • 치료법을 기준으로 목적지 치료 부문은 2023년 61.8%의 가장 큰 매출 점유율을 차지할 것으로 예상되며, 예측 기간 중 11.8%의 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.
  • 2023년 북미가 64.1%의 점유율을 차지하며 시장을 장악할 것으로 예상됩니다. 이는 이 지역의 첨단화된 의료 인프라, 유리한 상환 정책, 기술 발전, Abbott, BiVacor, SynCardia와 같은 주요 시장 기업의 존재가 이 지역 시장을 지배하고 있기 때문입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 인공심장 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 모시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
    • 시장 촉진요인 분석
    • 시장 억제요인 분석
  • 인공심장 시장 분석 툴
    • 업계 분석 - Porter의 산업 분석
    • PESTEL 분석

제4장 인공심장 시장 : 유형 추정·동향 분석

  • 인공심장 시장 : 유형 대시보드
  • 인공심장 시장 : 유형 변동 분석
  • 인공심장 시장 규모와 예측 및 동향 분석, 유형별, 2018-2030년
  • LVAD
  • 인공심폐
  • 완전 인공심장

제5장 인공심장 시장 : 치료법 추정·동향 분석

  • 인공심장 시장 : 치료법 대시보드
  • 인공심장 시장 : 치료법 변동 분석
  • 인공심장 시장 규모와 예측 및 동향 분석, 치료법별, 2018-2030년
  • BTT
  • DT
  • BTD
  • 기타

제6장 인공심장 시장 : 국, 유형, 치료법별 지역 추정·동향 분석

  • 인공심장 시장 : 지역 대시보드
  • 시장 규모와 예측 동향 분석, 2018-2030년
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제7장 경쟁 구도

  • 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
  • 기업/경쟁 분류
  • 벤더 구도
    • 주요 유통업체 및 채널 파트너 리스트
    • 주요 고객
    • 주요 기업의 시장 점유율 분석, 2023년
    • SynCardia Systems, LLC
    • CARMAT
    • BiVacor
    • RealHeart
    • Abbott
    • Abiomed(Johnson &Johnson Services Inc)
    • Jarvik Heart, Inc
    • LivaNova PLC
    • Getinge AB
    • Terumo
KSA 24.06.21

Artificial Heart Market Growth & Trends:

The global artificial heart market size is expected to reach USD 5.94 billion by 2030, registering a CAGR of 11.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by various factors such as the increasing burden of cardiovascular diseases, technological advancements in the field, a growing geriatric population, and lifestyle changes leading to higher cardiovascular risks. As the global population ages, there is an increased incidence of cardiac issues among older individuals. This demographic trend contributes to the demand for artificial hearts as a treatment option for heart failure and other conditions.

The global burden of CVDs is increasing, driven by the aging population, sedentary lifestyles, and unhealthy diets. According to an article by NCBI in May 2022, 92.1 million Americans are affected by some form of CVD, and it is predicted that 43.9% will have some type of CVD by 2030. Similarly, according to the British Heart Foundation's July 2022 report, 4 million men and 3.6 million women lived with heart and circulatory diseases in 2021. Continued investment in research aimed at improving cardiac patient outcomes drives adoption rates for artificial hearts. In January 2024, CARMAT introduced a new software enhancement for its artificial heart Aeson, aiming to enhance its safety profile by enabling real-time defect detection and modifying control to provide continuous patient care.

Artificial Heart Market Report Highlights:

  • Based on type, the left ventricular assist device (LVAD) segment held the largest market share of 77.40% in 2023. The rising prevalence of heart failure globally has contributed significantly to the growth of the LVAD market
  • Based on therapy, the destination therapy segment accounted for the largest revenue share of 61.8% in 2023 and is expected to witness the fastest CAGR of 11.8% during the forecast period. owing to the increasing prevalence of advanced heart failure patients who are ineligible for heart transplantation or other therapies
  • In 2023, North America dominated the market with a share of 64.1% due to the advanced healthcare infrastructure, favorable reimbursement policies, and technological advancements in the region. The presence of major market players such as Abbott, BiVacor and SynCardia dominates the market in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Therapy
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. Commodity price analysis (Model 1)
  • 1.9. Approach 1: Commodity flow approach
  • 1.10. List of Secondary Sources
  • 1.11. List of Primary Sources
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Therapy outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Heart Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver Analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Artificial Heart Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Artificial Heart Market: Type Estimates & Trend Analysis

  • 4.1. Artificial Heart Market: Type Dashboard
  • 4.2. Artificial Heart Market: Type Movement Analysis
  • 4.3. Artificial Heart Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. LVADs
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Heart-lung Machine
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Total Artificial Heart
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Artificial Heart Market: Therapy Estimates & Trend Analysis

  • 5.1. Artificial Heart Market: Therapy Dashboard
  • 5.2. Artificial Heart Market: Therapy Movement Analysis
  • 5.3. Artificial Heart Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 5.4. Bridge to transplant
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Destination Therapy
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Bridge to decision
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Artificial Heart Market: Regional Estimates & Trend Analysis by Country, Type & Therapy

  • 6.1. Artificial Heart Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. SynCardia Systems, LLC
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. CARMAT
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. BiVacor
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. RealHeart
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Abbott
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Abiomed (Johnson & Johnson Services Inc)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Jarvik Heart, Inc
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. LivaNova PLC
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Getinge AB
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Terumo
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제